Harbin Pharmaceutical Group Co Stock

Harbin Pharmaceutical Group Co P/B

The P/B (Price-to-Book Ratio) of Harbin Pharmaceutical Group Co (600664.SS) as of Aug 25, 2026 is 1.68. In the previous year, P/B (Price-to-Book Ratio) was 1.90 — a change of -11.70% (lower).

P/B

1.68

YoY

-11.70%

Last updated:

P/B (Price-to-Book Ratio) of Harbin Pharmaceutical Group Co is 2026 1.68 . P/B (Price-to-Book Ratio) of Harbin Pharmaceutical Group Co was 2025 1.90 . It decreases by -11.70% lower compared to the previous year.

The Harbin Pharmaceutical Group Co P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2017
1.27 CNY
Jan 1, 2018
1.53 CNY
Jan 1, 2019
1.65 CNY
Jan 1, 2020
2.58 CNY
Jan 1, 2021
2.34 CNY
Jan 1, 2022
2.08 CNY
Jan 1, 2023
1.90 CNY
Jan 1, 2024
1.68 CNY
The Harbin Pharmaceutical Group Co P/B history
YEARP/BYoY
1.68-11.70%
1.90-8.32%
2.08-11.17%
2.34-9.55%
2.58+56.81%
1.65+7.48%
1.53+20.24%
1.27+11.34%
1.15-10.18%
1.27+16.80%
1.09
Access this data via the Eulerpool API

Harbin Pharmaceutical Group Co Stock analysis

What does Harbin Pharmaceutical Group Co do? Harbin Pharmaceutical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harbin Pharmaceutical Group Co stock

P/B (Price-to-Book Ratio) of Harbin Pharmaceutical Group Co is 1.68 in 2026.

P/B (Price-to-Book Ratio) of Harbin Pharmaceutical Group Co changed from 1.90 to 1.68, representing a -11.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Harbin Pharmaceutical Group Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Harbin Pharmaceutical Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Harbin Pharmaceutical Group Co

All Key Metrics — Harbin Pharmaceutical Group Co